BD PharmingenTM Biotin Mouse Anti-Mouse Vbeta 5.1, 5.2 T-Cell Receptor

Description

Two-color flow cytometric analysis of the expression of Vbeta 5.1, 5.2 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with Biotin Mouse Anti-Mouse Vbeta 5.1, 5.2 T-Cell Receptor Cat. No. 553188 , PE Rat Anti-Mouse CD4 Cat. No. 553048/553049 , and PE Rat Anti-Mouse CD8a Cat. No. 553032/553033 monoclonal antibodies, followed by Avidin FITC Cat. No. 554057 . The fluorescence contour plot was derived from gated events based on the forward and side light-scattering of viable lymphocytes. Flow cytometry was performed on a FACScan. Two-color flow cytometric analysis of the expression of Vbeta 5.1, 5.2 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with Biotin Mouse Anti-Mouse Vbeta 5.1, 5.2 T-Cell Receptor Cat. No. 553188 , PE Rat Anti-Mouse CD4 Cat. No. 553048/553049 , and PE Rat Anti-Mouse CD8a Cat. No. 553032/553033 monoclonal antibodies, followed by Avidin FITC Cat. No. 554057 . The fluorescence contour plot was derived from gated events based on the forward and side light-scattering of viable lymphocytes. Flow cytometry was performed on a FACScan. Show More Two-color flow cytometric analysis of the expression of Vbeta 5.1, 5.2 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with Biotin Mouse Anti-Mouse Vbeta 5.1, 5.2 T-Cell Receptor Cat. No. 553188 , PE Rat Anti-Mouse CD4 Cat. No. 553048/553049 , and PE Rat Anti-Mouse CD8a Cat. No. 553032/553033 monoclonal antibodies, followed by Avidin FITC Cat. No. 554057 . The fluorescence contour plot was derived from gated events based on the forward and side light-scattering of viable lymphocytes. Flow cytometry was performed on a FACScan.